Literature DB >> 31970172

Relationship between β-amyloid protein 1-42, thyroid hormone levels and the risk of cognitive impairment after ischemic stroke.

Lei Mao1, Xiao-Han Chen1, Jian-Hua Zhuang1, Peng Li1, Yi-Xin Xu1, Yu-Chen Zhao1, Yue-Jin Ma1, Bin He1, You Yin2.   

Abstract

BACKGROUND: Post-stroke cognitive impairment (PSCI) is not only a common consequence of stroke but also an important factor for adverse prognosis of patients. Biochemical indicators such as blood lipids and blood pressure are affected by many factors, and the ability of evaluating the progress of patients with PSCI is insufficient. Therefore, it is necessary to find sensitive markers for predicting the progress of patients and avoiding PSCI. Recent studies have shown that β-amyloid protein 1-42 (Aβ1-42) and thyroid hormone levels are closely related to PSCI, which may be the influencing factors of PSCI, but there are few related studies. AIM: To investigate the relationship between serum levels of Aβ and thyroid hormones in acute stage and PSCI and its predicted value.
METHODS: A total of 195 patients with acute cerebral infarction confirmed from June 2016 to January 2018 were enrolled in this study. Baseline data and serological indicators were recorded to assess cognitive function of patients. All patients were followed up for 1 year. Their cognitive functions were evaluated within 1 wk, 3 mo, 6 mo and 1 yr after stroke. At the end of follow-up, the patients were divided into PSCI and non-PSCI according to Montreal cognitive assessment score, and the relationship between biochemical indexes and the progression of PSCI was explored.
RESULTS: Compared with patients with non-PSCI, the levels of Aβ1-42, triiodothyronine (T3) and free thyroxin were lower in the patients with PSCI. Repeated measures analysis of variance showed that the overall content of Aβ1-42 and T3 in PSCI was also lower than that of the non-PSCI patients. Further analysis revealed that Aβ1-42 (r = 0.348), T3 (r = 0.273) and free thyroxin (r = 0.214) were positively correlated with disease progression (P < 0.05), suggesting that these indicators have the potential to predict disease progression and outcome. Cox regression analysis showed that Aβ1-42 and T3 were important factors of PSCI. Then stratified analysis showed that the lower the Aβ1-42 and T3, the higher risk of PSCI in patients who were aged over 70, female and illiterate.
CONCLUSION: Aβ1-42 and T3 have the ability to predict the progression of PSCI, which is expected to be applied clinically to reduce the incidence of PSCI and improve the quality of life of patients. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Free thyroxin; Montreal cognitive assessment; Post-stroke cognitive impairment; Prognosis; Triiodothyronine; β-amyloid protein

Year:  2020        PMID: 31970172      PMCID: PMC6962069          DOI: 10.12998/wjcc.v8.i1.76

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  35 in total

1.  Cognitive-communication disorder following right hemisphere stroke: exploring rehabilitation access and outcomes.

Authors:  Ronelle Hewetson; Petrea Cornwell; David Shum
Journal:  Top Stroke Rehabil       Date:  2017-02-20       Impact factor: 2.119

2.  Low T3 levels as a predictor marker predict the prognosis of patients with acute ischemic stroke.

Authors:  Yiping Wang; Saijun Zhou; Jianhong Bao; Sipei Pan; Xu Zhang
Journal:  Int J Neurosci       Date:  2016-07-27       Impact factor: 2.292

3.  Determinants of post-stroke cognitive impairment: analysis from VISTA.

Authors:  F Arba; T Quinn; G J Hankey; D Inzitari; M Ali; K R Lees
Journal:  Acta Neurol Scand       Date:  2016-07-13       Impact factor: 3.209

4.  Atrial Fibrillation is Independently Associated with Cognitive Impairment after Ischemic Stroke.

Authors:  Russell Jude Chander; Levinia Lim; Sagarika Handa; Shaun Hiu; Angeline Choong; Xuling Lin; Rajinder Singh; Daniel Oh; Nagaendran Kandiah
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  The test accuracy of the Montreal Cognitive Assessment (MoCA) by stroke lateralisation.

Authors:  Edgar Chan; Samantha Altendorff; Colm Healy; David J Werring; Lisa Cipolotti
Journal:  J Neurol Sci       Date:  2016-12-19       Impact factor: 3.181

6.  Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.

Authors:  Zhiqian Tong; Weishan Wang; Wenhong Luo; Jihui Lv; Hui Li; Hongjun Luo; Jianping Jia; Rongqiao He
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Post-stroke cognitive decline: an update and perspectives for clinical research.

Authors:  M Brainin; J Tuomilehto; W-D Heiss; N M Bornstein; P M W Bath; Y Teuschl; E Richard; A Guekht; T Quinn
Journal:  Eur J Neurol       Date:  2014-12-09       Impact factor: 6.089

Review 8.  Stroke injury, cognitive impairment and vascular dementia.

Authors:  Raj N Kalaria; Rufus Akinyemi; Masafumi Ihara
Journal:  Biochim Biophys Acta       Date:  2016-01-22

9.  Predictors for vascular cognitive impairment in stroke patients.

Authors:  Xiangliang Chen; Lihui Duan; Yunfei Han; Ling Tian; Qiliang Dai; Shang Wang; Ying Lin; Yunyun Xiong; Xinfeng Liu
Journal:  BMC Neurol       Date:  2016-07-26       Impact factor: 2.474

10.  ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.

Authors:  Alla Guekht; Ingmar Skoog; Sally Edmundson; Vladimir Zakharov; Amos D Korczyn
Journal:  Stroke       Date:  2017-05       Impact factor: 7.914

View more
  4 in total

1.  Cognitive decline according to amyloid uptake in patients with poststroke cognitive impairment.

Authors:  Bora Yoon; Dong Won Yang; Yun-Jeong Hong; Taewon Kim; Seunghee Na; Sang-Mi Noh; Hye Lim Park; Bon D Ku; Young Soon Yang; Hojin Choi; Jae-Won Jang; Seongheon Kim; Yerim Kim; YongSoo Shim
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

Review 2.  Is Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment?

Authors:  Fubing Ouyang; Zimu Jiang; Xinran Chen; Yicong Chen; Jiating Wei; Shihui Xing; Jian Zhang; Yuhua Fan; Jinsheng Zeng
Journal:  Transl Stroke Res       Date:  2021-06-30       Impact factor: 6.829

Review 3.  Association of Blood Amyloid Beta-Protein 1-42 with Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Hui Chen; Sichun Gu; Xiaoying Liu; Anjie Xie; Changde Wang
Journal:  Biomed Res Int       Date:  2022-03-30       Impact factor: 3.411

4.  Relationship between Prognosis with Dynamic Changes of Thyroid Hormone and Cortisol Hormone in Patients with Severe Craniocerebral Injury.

Authors:  Chuang Ding; Jianbo Liu; Kejun Liu; Xiaoteng Yao
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-19       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.